Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Abstract
:1. Introduction
2. Spectrum of ME/CFS Severity
3. Clinical Features Prominent in Severe and Very Severe ME/CFS
- Profound weakness. May be unable to move or turn over in bed, eat, get to the toilet, etc.
- Reduced or lack of ability to speak or swallow.
- Severe and often almost constant, widespread pain, severe headaches, and hyperesthesia.
- Extreme intolerance to small amounts of physical, mental, emotional, or orthostatic stressors such as sitting, bathing, toileting, eating, speaking. These can trigger post-exertional malaise and increased weakness.
- Hypersensitivity, sometimes extreme, to light, sound, touch, chemicals, or odors. Exposure can increase pain and other symptoms.
- Severe cognitive impairment that may impede the patient’s ability to communicate and understand written materials.
- Severe gastrointestinal disturbances (e.g., nausea, abdominal pain), early satiety, and food intolerances which can impair adequate nutrition.
- Orthostatic intolerance severe enough to prevent upright posture.
- Sleep dysfunction such as unrefreshing sleep, shifted sleep cycles, and fractured sleep.
- Increased prevalence of comorbidities common to ME/CFS (e.g., mast cell activation syndrome, postural orthostatic tachycardia syndrome) and/or complications of being homebound or bedbound (e.g., osteoporosis, constipation, pressure ulcers, aspiration pneumonia, depression, and deconditioning). These can increase disease burden and complicate management.
4. Providing Compassionate Care for Severe and Very Severe ME/CFS
- Respect the nature and severity of the patient’s disease in all clinical interactions [10]. Ask patients and caregivers beforehand about any factors (e.g., fragrances, fast movements, brightly colored clothes, loud noises, bright lights, and touch) that exacerbate the patient’s specific sensory sensitivities. Minimize these factors as much as possible. Interact with patients at a pace, time of day, and length of time the patient can manage. Even home visits may tax the patient so leverage the caretaker where possible to conserve the patient’s limited energy. Creative approaches may be required if the patient’s ability to speak is limited.
- Accept the validity of the patient’s report of symptoms. Gain the trust of the patient, caregiver, and family. Listen to what they report with understanding and compassion.
- Be honest about the limits of medical knowledge but reassure the patient that you will do what you can to help them.
- Partner closely with the caregiver, if one is involved, and if needed, other healthcare professionals to provide the resources, services, education, and practical help needed by the patient and caregiver. A specialty consultation may help diagnose and manage those aspects of ME/CFS with which you are unfamiliar. Engage a targeted set of other professionals as necessary and as tolerated by the patient. These could include physical therapists, occupational therapists, nurses, home health aides, social workers, and mental health experts. Home visits by optometrists/ophthalmologists and dentists may be required. Ensure these other professionals are knowledgeable about ME/CFS.
- While providing access to essential healthcare providers, care must be taken not to overwhelm the patient with too many providers or too many visits. Where feasible, leverage the caregiver to save the patient’s energy. For example, capitalize on the caregiver’s intimate knowledge of the patient’s needs, preferences, and status. Teach them to provide certain services to minimize the need for additional healthcare providers. Reserve patient visits for those times where patient input is required or there is a need to examine the patient in-person.
- Be alert to caregiver stress. Community resources, local support groups, and respite services for those caring for people with ME/CFS or other chronic diseases may be helpful.
- Some severely ill ME/CFS patients may not have caregivers. Be alert to their non-medical needs, such as their ability to obtain and prepare food.
5. Diagnosis and Assessment
- In addition to the diagnostic approaches used for all ME/CFS patients [1,12,13,28,29], the following assessments are particularly important for the person with severe or very severe ME/CFS [8,10,13,14,16,17,30]: Evaluate the patient’s basic and instrumental activities of daily living (ADLs and IADLs) (Table 2). Documenting ADLs has the added benefit of supporting applications for disability.
- Assess the patient’s individual energy limits (their “energy envelope”) [31] and the energy they expend on ADLs and IADLs.
- Investigate medical issues that may be impacting the patient’s symptom burden or level of functioning. These could include over-exertion resulting in PEM, untreated orthostatic intolerance, pain, sleep difficulties, gastrointestinal issues, unrecognized sensory hypersensitivities, recurrent infections, comorbidities, or complications from being homebound or bedbound. Each symptom should be assessed individually to determine whether it is the result of another specific diagnosis that needs to also be treated [8,12,13,16].
- Assess the patient’s psychological status using methods appropriate for chronic disease. Pay attention to affective symptoms (e.g., sadness, worry) and be careful about attributing somatic symptoms (e.g., fatigue, insomnia, gastrointestinal disturbances) to psychological/psychiatric conditions.
- Assess non-medical issues that contribute to the patient’s level of morbidity. Examples include lack of social services, caretaking, transportation, finances, food, and/or supportive devices.
6. Recommendations for Treatment and Management of Severe and Very Severe ME/CFS
6.1. Recommendations for Minimizing Post-Exertional Malaise and Sensory Sensitivities
- Ensure the patient and caregiver understand post-exertional malaise. Educate them about energy conservation strategies, such as pacing, to minimize the physical, mental, orthostatic, and emotional stressors that could trigger post-exertional malaise with its consequent worsening of symptoms and functioning [11,12,13,37].
- Minimize those stimuli to which the patient is sensitive, such as light, noise, touch, movement, chemicals, and odors, Exposure to these could increase pain and other symptoms (Table 2). The most severe patients may not be able to tolerate any touch, light or noise.
6.2. Recommendations for Treatment and Management Approaches
- Drugs should be used conservatively and parsimoniously [12,13,16]. When drugs are used, start with very low doses and titrate up slowly as tolerated. For instance, naltrexone is commonly used at 50 mg for opioid overdose but for pain in ME/CFS, the dose starts at 0.1 mg daily and titrates up to 4.5 mg daily. Decrease the risk of side effects and drug–drug interactions by favoring medications which may treat more than one symptom or condition, e.g., both pain and sleep.
- If other pain medications have not been effective or cause significant side effects, it may be necessary to consider opioid medications. Consider starting a medication to counter constipation at the time opioids are prescribed.
- Oral feeding and hydration are preferred and should be tried first. However, tube feeding may be required to ensure nutrition and to conserve the patient’s energy [8]. Intravenous saline may be needed for hydration. If necessary, intravenous feeding may be required as a last resort.
- Physical therapists may help with energy conservation approaches, pain management, joint protection to prevent joint contracture, body positioning, and gentle range of motion, stretching, and strength exercises to help address the effects of being inactive and bedbound (Table 2). The approaches used must be done in such a way that they do not trigger PEM or sensory sensitivities (e.g., to touch) [11,12,13,37]. Caution is advised as even passive straight leg lifts performed by a therapist have been shown to trigger PEM [38]. Caution on stretching is advised for patients with comorbid hypermobile Ehlers-Danlos syndrome.
- Speech language therapists can help evaluate and treat problems with eating/swallowing as well as problems with communication, whether they stem from anatomical or functional abnormalities in the oral/gastrointestinal tract or in the brain.
- Mental health providers may be able to help patients better cope with the debility of the disease [34].
- Educate the patient, family, and caregiver about helpful behavioral measures. For example, space out caregiving tasks to avoid overstimulation of the patient, adjust/turn the patient occasionally to decrease pressure ulcers, and lower expectations such as the need for a daily bath.
6.3. Recommendations for Follow-Up Visits, Advance Care Directives, and Hospitalization
- Schedule follow-up visits on a regular basis. Monitor for emerging comorbidities and complications and whether changes in management practices could help. Do not assume any new issues are caused by ME/CFS or are intractable.
- In the event of a hospital admission, advise staff of the need to provide a low sensory environment and limit the tests and encounters with hospital staff to the extent possible [7,14]. Advise surgeons of necessary precautions for those patients undergoing surgery [39]. Hospitals and clinics may also need information on how to differentiate between ME/CFS and mental illness [13,34].
- Encourage the patient and family to establish a living will, appoint a healthcare proxy, and consider a power of attorney to manage finances if needed. Additionally, encourage them to establish a contingency plan and maintain a summary of their health issues and medications in the event that hospitalization is necessary, or an emergency issue arises. Examples of emergency issues include a fire, loss of a caregiver (e.g., through death or illness), or a very severe relapse in which the patient can no longer communicate their needs.
ADL Domain/Tasks: | Recommendations, Including Modifications/Adaptations 2 |
---|---|
Grooming/ Washing |
|
Grooming/ Tooth Brushing |
|
Grooming/ Dressing |
|
Toileting |
|
Feeding and Drinking |
|
Positioning and Range of Motion | To protect the patient from pressure sores, joint contractures, skin and joint irritation, and poor alignment:
|
Environment/ Room Setup | To protect the patient from undue physical, cognitive, or emotional exertion:
|
Mobility and Transfers |
|
Support and Socialization |
|
Medical Management and Emergency Preparedness |
|
7. Practical Considerations for Busy Providers
- Document ADLs and IADLs to demonstrate the need for home care [40].
- Leverage a combination of home visits, telemedicine, written communications, partnerships with home health care services, partnership with the caregiver if one exists, and emerging remote monitoring technologies to best manage both the needs of the patient and the demands on your time. Delegate tasks which do not need your specific input (e.g., completing repetitive forms, gathering basic information) to clinic staff such as receptionists and medical assistants.
- Be aware of any regulatory or insurance requirements for providing home visits.
- Maximize reimbursement by diagnosing any comorbidities such as postural orthostatic tachycardia syndrome (POTS), Ehlers-Danlos syndrome (EDS), or mast cell activation syndrome (MCAS).
8. Pathology in Severe and Very Severe ME/CFS
9. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining An Illness; Institute of Medicine (U.S.), Ed.; The National Academies Press: Washington, DC, USA, 2015; ISBN 9780309316897. [Google Scholar]
- Komaroff, A.L. Advances in understanding the pathophysiology of chronic fatigue syndrome. JAMA 2019, 322, 499–500. [Google Scholar] [CrossRef]
- Komaroff, A.L.; Lipkin, W.I. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol. Med. 2021, 27, 895–906. [Google Scholar] [CrossRef] [PubMed]
- Lim, E.-J.; Ahn, Y.-C.; Jang, E.-S.; Lee, S.-W.; Lee, S.-H.; Son, C.-G. Systematic Review and Meta-Analysis of the Prevalence of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). J. Transl. Med. 2020, 18, 100. [Google Scholar] [CrossRef]
- Unger, E.R.; Lin, J.-M.S.; Tian, H.; Natelson, B.H.; Lange, G.; Vu, D.; Blate, M.; Klimas, N.G.; Balbin, E.G.; Bateman, L.; et al. Multi-site clinical assessment of myalgic encephalomyelitis/chronic fatigue syndrome (MCAM): Design and implementation of a prospective/retrospective rolling cohort study. Am. J. Epidemiol. 2017, 185, 617–626. [Google Scholar] [CrossRef] [Green Version]
- Pendergrast, T.; Brown, A.; Sunnquist, M.; Jantke, R.; Newton, J.L.; Strand, E.B.; Jason, L.A. Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. 2016, 12, 292–307. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Timbol, C.R.; Baraniuk, J.N. Chronic fatigue syndrome in the emergency department. Open Access Emerg. Med. 2019, 11, 15–28. [Google Scholar] [CrossRef] [Green Version]
- Baxter, H.; Speight, N.; Weir, W. Life-threatening malnutrition in very severe ME/CFS. Healthcare 2021, 9, 459. [Google Scholar] [CrossRef]
- Williams, L.R.; Isaacson-Barash, C. Three cases of severe ME/CFS in adults. Healthcare 2021, 9, 215. [Google Scholar] [CrossRef] [PubMed]
- Kingdon, C.; Giotas, D.; Nacul, L.; Lacerda, E. Health care responsibility and compassion-visiting the housebound patient severely affected by ME/CFS. Healthcare 2020, 8, 197. [Google Scholar] [CrossRef]
- Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Primer for Clinical Practitioners. 2014 Edition. International Association for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Available online: https://growthzonesitesprod.azureedge.net/wp-content/uploads/sites/1869/2020/10/Primer_Post_2014_conference.pdf (accessed on 21 June 2021).
- Bateman, L.; Bested, A.C.; Bonilla, H.F.; Chheda, B.V.; Chu, L.; Curtin, J.M.; Dempsey, T.T.; Dimmock, M.E.; Dowell, T.G.; Felsenstein, D.; et al. Myalgic encephalomyelitis/chronic fatigue syndrome: Essentials of diagnosis and management. Mayo Clin. Proc. 2021. [Google Scholar] [CrossRef] [PubMed]
- Rowe, P.C.; Underhill, R.A.; Friedman, K.J.; Gurwitt, A.; Medow, M.S.; Schwartz, M.S.; Speight, N.; Stewart, J.M.; Vallings, R.; Rowe, K.S. Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: A primer. Front. Pediatr. 2017, 5, 121. [Google Scholar] [CrossRef] [Green Version]
- UK National Institute for Health and Care Excellence. Guideline: Myalgic Encephalomyelitis (or Encephalopathy)/Chronic Fatigue Syndrome: Diagnosis and Management. Draft for Consultation. November 2020. Available online: https://www.nice.org.uk/guidance/indevelopment/gid-ng10091 (accessed on 26 June 2021).
- Centers for Disease Control and Prevention. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Information for Healthcare Providers: Severely Affected Patients. Available online: https://www.cdc.gov/me-cfs/healthcare-providers/clinical-care-patients-mecfs/severely-affected-patients.html (accessed on 26 June 2021).
- Speight, N. Severe ME in children. Healthcare 2020, 8, 211. [Google Scholar] [CrossRef] [PubMed]
- Dialogues of a Neglected Illness. Severe and Very Severe ME/CFS. 2020. Available online: https://www.dialogues-mecfs.co.uk/films/severeme/ (accessed on 26 June 2021).
- Cox, D.L.; Findley, L.J. The management of chronic fatigue syndrome in an inpatient setting: Presentation of an approach and perceived outcome. Br. J. Occup. Ther. 1998, 61, 405–409. [Google Scholar] [CrossRef]
- Carruthers, B.M.; van de Sande, M.I.; De Meirleir, K.L.; Klimas, N.G.; Broderick, G.; Mitchell, T.; Staines, D.; Powles, A.C.P.; Speight, N.; Vallings, R.; et al. Myalgic encephalomyelitis: International consensus criteria. J. Intern. Med. 2011, 270, 327–338. [Google Scholar] [CrossRef] [Green Version]
- Conroy, K.; Bhatia, S.; Islam, M.; Jason, L.A. Homebound versus bedridden status among those with myalgic encephalomyelitis/chronic fatigue syndrome. Healthcare 2021, 9, 106. [Google Scholar] [CrossRef]
- van Campen, C.M.C.; Rowe, P.C.; Visser, F.C. Two-day cardiopulmonary exercise testing in females with a severe grade of myalgic encephalomyelitis/chronic fatigue syndrome: Comparison with patients with mild and moderate disease. Healthcare 2020, 8, 192. [Google Scholar] [CrossRef] [PubMed]
- van Campen, C.M.C.; Rowe, P.C.; Visser, F.C. Validation of the severity of myalgic encephalomyelitis/chronic fatigue syndrome by other measures than history: Activity bracelet, cardiopulmonary exercise testing and a validated activity questionnaire: SF-36. Healthcare 2020, 8, 273. [Google Scholar] [CrossRef]
- Kingdon, C.C.; Bowman, E.W.; Curran, H.; Nacul, L.; Lacerda, E.M. Functional status and well-being in people with myalgic encephalomyelitis/chronic fatigue syndrome compared with people with multiple sclerosis and healthy controls. PharmacoEcon. Open 2018, 2, 381–392. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Komaroff, A.L.; Fagioli, L.R.; Doolittle, T.H.; Gandek, B.; Gleit, M.A.; Guerriero, R.T.; Kornish, R.J.; Ware, N.C.; Ware, J.E.; Bates, D.W. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am. J. Med. 1996, 101, 281–290. [Google Scholar] [CrossRef]
- Natelson, B.H.; Lin, J.-M.S.; Lange, G.; Khan, S.; Stegner, A.; Unger, E.R. The effect of comorbid medical and psychiatric diagnoses on chronic fatigue syndrome. Ann. Med. 2019, 51, 371–378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cairns, R.; Hotopf, M. A Systematic review describing the prognosis of chronic fatigue syndrome. Occup. Med. (Lond.) 2005, 55, 20–31. [Google Scholar] [CrossRef] [Green Version]
- Dafoe, W. Extremely severe ME/CFS-A personal account. Healthcare 2021, 9, 504. [Google Scholar] [CrossRef]
- Centers for Disease Control and Prevention. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Available online: https://www.cdc.gov/me-cfs/index.html (accessed on 26 June 2021).
- US ME/CFS Clinician Coalition Website. Available online: https://mecfscliniciancoalition.org/ (accessed on 26 June 2021).
- Collingridge, Emily. Severe ME/CFS. A Guide to Living. 2010. Available online: http://www.severeme.info/ (accessed on 26 June 2021).
- Jason, L.A.; Brown, M.; Brown, A.; Evans, M.; Flores, S.; Grant-Holler, E.; Sunnquist, M. Energy conservation/envelope theory interventions. Fatigue 2013, 1, 27–42. [Google Scholar] [CrossRef] [Green Version]
- Colby, J. Special problems of children with myalgic encephalomyelitis/chronic fatigue syndrome and the enteroviral link. J. Clin. Pathol. 2006, 60, 125–128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chu, L.; Elliott, M.; Stein, E.; Jason, L.A. Identifying and managing suicidality in myalgic encephalomyelitis/chronic fatigue syndrome. Healthcare 2021, 9, 629. [Google Scholar] [CrossRef] [PubMed]
- Stein, E. Chronic Fatigue Syndrome. Assessment and Treatment of Patients with ME/CFS: Clinical Guidelines for Psychiatrists. 2005. Available online: https://s3.amazonaws.com/kajabi-storefronts-production/sites/90617/themes/1513565/downloads/TSGDbZnFSWOjdt3msZgv_Guidelines-Paper-English.pdf (accessed on 26 June 2021).
- Keller, B.A.; Pryor, J.; Giloteaux, L. Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment. J. Transl. Med. 2014, 12, 104. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Geraghty, K.; Hann, M.; Kurtev, S. Myalgic encephalomyelitis/chronic fatigue syndrome patients’ reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys. J. Health Psychol. 2019, 24, 1318–1333. [Google Scholar] [CrossRef]
- Campbell, B.; Lapp, C. Treating Chronic Fatigue Syndrome and Fibromyalgia. Guidance on Pacing. Available online: http://www.treatcfsfm.org/menu-Pacing-7.html (accessed on 26 June 2021).
- Rowe, P.C.; Fontaine, K.R.; Lauver, M.; Jasion, S.E.; Marden, C.L.; Moni, M.; Thompson, C.B.; Violand, R.L. Neuromuscular strain increases symptom intensity in chronic fatigue syndrome. PLoS ONE 2016, 11, e0159386. [Google Scholar] [CrossRef] [Green Version]
- Lapp, C. Recommendations for Persons with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Who Are Anticipating Surgery or Anesthesia. Available online: https://docs.google.com/document/d/1MSiO2EInryV3uCrLpUWzGW4HmlLIghsJnDjGQAo3Qaw/edit (accessed on 26 June 2021).
- Occupational therapy practice framework: Domain and process (3rd ed.). Am. J. Occup. Ther. 2017, 68 (Suppl. 1), S1. Available online: https://www.aota.org/~/media/Corporate/Files/Advocacy/Federal/coding/OT-Practice-Framework-Table-1-Occupations.pdf (accessed on 26 June 2021).
- Strassheim, V.; Lambson, R.; Hackett, K.L.; Newton, J.L. What Is known about severe and very severe chronic fatigue syndrome? A scoping review. Fatigue 2017, 5, 167–183. [Google Scholar] [CrossRef]
- Tomas, C.; Elson, J.L.; Strassheim, V.; Newton, J.L.; Walker, M. The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function. PLoS ONE 2020, 15, e0231136. [Google Scholar] [CrossRef] [PubMed]
- Montoya, J.G.; Holmes, T.H.; Anderson, J.N.; Maecker, H.T.; Rosenberg-Hasson, Y.; Valencia, I.J.; Chu, L.; Younger, J.W.; Tato, C.M.; Davis, M.M. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc. Natl. Acad. Sci. USA 2017, 1114, E7150–E7158. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hardcastle, S.L.; Brenu, E.W.; Johnston, S.; Nguyen, T.; Huth, T.; Ramos, S.; Staines, D.; Marshall-Gradisnik, S. Longitudinal analysis of immune abnormalities in varying severities of chronic fatigue syndrome/myalgic encephalomyelitis patients. J. Transl. Med. 2015, 13, 299. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van Campen, C.M.C.; van Rowe, P.C.; Visser, F.C. Reductions in cerebral blood flow can be provoked by sitting in severe myalgic encephalomyelitis/chronic fatigue syndrome patients. Healthcare 2020, 8, 394. [Google Scholar] [CrossRef]
- Van Campen, C.M.C.; Rowe, P.C.; Visser, F.C. Cerebral blood flow Is reduced in severe myalgic encephalomyelitis/chronic fatigue syndrome patients during mild orthostatic stress testing: An exploratory study at 20 degrees of head-up tilt testing. Healthcare 2020, 8, 169. [Google Scholar] [CrossRef]
Level of Severity | Description of Level of Functioning and Disease Severity |
---|---|
Mild | Mobile and able to self-care. May be working or attending school, but often with accommodations and by reducing other domestic and social activities. |
Moderate | Reduced mobility and restricted activities of daily living. Requires frequent rest periods and typically not working or attending school. |
Severe | Mostly homebound. Limited activities of daily living (e.g., self-care, showering, dressing). Severe cognitive difficulties. May be wheelchair dependent. |
Very Severe | Bedbound. Unable to carry out most activities of daily living for themselves. Often extreme sensory sensitivity to light, sound, touch, etc. May need total care. |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Montoya, J.G.; Dowell, T.G.; Mooney, A.E.; Dimmock, M.E.; Chu, L. Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Healthcare 2021, 9, 1331. https://doi.org/10.3390/healthcare9101331
Montoya JG, Dowell TG, Mooney AE, Dimmock ME, Chu L. Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Healthcare. 2021; 9(10):1331. https://doi.org/10.3390/healthcare9101331
Chicago/Turabian StyleMontoya, Jose G., Theresa G. Dowell, Amy E. Mooney, Mary E. Dimmock, and Lily Chu. 2021. "Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome" Healthcare 9, no. 10: 1331. https://doi.org/10.3390/healthcare9101331
APA StyleMontoya, J. G., Dowell, T. G., Mooney, A. E., Dimmock, M. E., & Chu, L. (2021). Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Healthcare, 9(10), 1331. https://doi.org/10.3390/healthcare9101331